Literature DB >> 27530206

2015 President's Plenary International Psycho-oncology Society: psychosocial care as a human rights issue-challenges and opportunities.

Luzia Travado1, William Breitbart2, Luigi Grassi3, Daisuke Fujisawa4, Andrea Patenaude5, Lea Baider6, Stephen Connor7, Michelle Fingeret8.   

Abstract

The International Psycho-Oncology Society (IPOS) Human Rights Task Force has been working since 2008 to raise awareness and support, for the relevance of psychosocial cancer care as a human rights issue. In 2014 the "Lisbon Declaration: Psychosocial Cancer Care as a Universal Human Right" was fully endorsed by IPOS. Subsequently, the IPOS Standard on Quality Cancer Care, endorsed by 75 cancer organizations worldwide, has been updated and now includes 3 core principles: Psychosocial cancer care should be recognised as a universal human right; Quality cancer care must integrate the psychosocial domain into routine care; Distress should be measured as the 6th vital sign. The President's plenary held at the 2015 World Congress of Psycho-Oncology in Washington DC was devoted to discussing psychosocial care as a human rights issue. Many challenges and opportunities are illustrated in different continents and contexts: from Africa where resources for basic cancer treatment are scarce and children and their parents face significant difficulties with hospital detention practices; to Europe where for many countries psychosocial care is still seen as a luxury; and the Middle East where Muslim women face stigma and a culture of silence over cancer. We further discuss how to move the Lisbon Declaration forward towards its implementation into clinical practice globally, using the successful example of the World Health Assembly resolution supporting palliative care as a human right which has achieved widespread approval, and identifying the vital role the IPOS Federation of National Psychoncology Societies plays worldwide to move this agenda forward.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  human rights; psycho-oncology; psychosocial cancer care; standards of cancer care

Mesh:

Year:  2016        PMID: 27530206      PMCID: PMC5494596          DOI: 10.1002/pon.4209

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  18 in total

1.  Abandonment of childhood cancer treatment in Western Kenya.

Authors:  F Njuguna; S Mostert; A Slot; S Langat; J Skiles; M N Sitaresmi; P M van de Ven; J Musimbi; H Muliro; R C Vreeman; G J L Kaspers
Journal:  Arch Dis Child       Date:  2014-03-28       Impact factor: 3.791

2.  Screening for distress, the 6th vital sign: where are we, and where are we going?

Authors:  Barry D Bultz; Christoffer Johansen
Journal:  Psychooncology       Date:  2011-06       Impact factor: 3.894

3.  Standards for the Psychosocial Care of Children With Cancer and Their Families: An Introduction to the Special Issue.

Authors:  Lori Wiener; Anne E Kazak; Robert B Noll; Andrea Farkas Patenaude; Mary Jo Kupst
Journal:  Pediatr Blood Cancer       Date:  2015-09-23       Impact factor: 3.167

Review 4.  What is patient safety culture? A review of the literature.

Authors:  Christine E Sammer; Kristine Lykens; Karan P Singh; Douglas A Mains; Nuha A Lackan
Journal:  J Nurs Scholarsh       Date:  2010-06       Impact factor: 3.176

5.  Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC).

Authors:  Luzia Travado; Joaquim C Reis; Maggie Watson; Josep Borràs
Journal:  Psychooncology       Date:  2015-12-21       Impact factor: 3.894

Review 6.  A new quality standard: the integration of psychosocial care into routine cancer care.

Authors:  Paul B Jacobsen; Lynne I Wagner
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

Review 7.  Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.

Authors:  Hellen Gelband; Rengaswamy Sankaranarayanan; Cindy L Gauvreau; Susan Horton; Benjamin O Anderson; Freddie Bray; James Cleary; Anna J Dare; Lynette Denny; Mary K Gospodarowicz; Sumit Gupta; Scott C Howard; David A Jaffray; Felicia Knaul; Carol Levin; Linda Rabeneck; Preetha Rajaraman; Terrence Sullivan; Edward L Trimble; Prabhat Jha
Journal:  Lancet       Date:  2015-11-11       Impact factor: 79.321

8.  Hospital detention practices: statement of a global taskforce.

Authors:  Saskia Mostert; Catherine G Lam; Festus Njuguna; Andrea F Patenaude; Ketan Kulkarni; Carmen Salaverria
Journal:  Lancet       Date:  2015-08-15       Impact factor: 79.321

Review 9.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

10.  Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya.

Authors:  S Mostert; F Njuguna; P M van de Ven; G Olbara; L J P A Kemps; J Musimbi; R M Strother; L M Aluoch; J Skiles; N G Buziba; M N Sitaresmi; R C Vreeman; G J L Kaspers
Journal:  Pediatr Blood Cancer       Date:  2013-12-17       Impact factor: 3.167

View more
  8 in total

1.  Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed.

Authors:  Josée Savard; Hans Ivers
Journal:  Support Care Cancer       Date:  2019-02-04       Impact factor: 3.603

2.  What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital.

Authors:  Saira Sanjida; Kelly Mulvogue; Joanne Shaw; Jeremy Couper; David Kissane; Sallie-Anne Pearson; Melanie A Price; Monika Janda
Journal:  Support Care Cancer       Date:  2017-09-19       Impact factor: 3.603

Review 3.  Advances in pediatric psychooncology.

Authors:  Lori Wiener; Katie A Devine; Amanda L Thompson
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

Review 4.  Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Authors:  Sudha Sivaram; Gautam Majumdar; Douglas Perin; Ashrafun Nessa; Mireille Broeders; Elsebeth Lynge; Mona Saraiya; Nereo Segnan; Rengaswamy Sankaranarayanan; Preetha Rajaraman; Edward Trimble; Stephen Taplin; G K Rath; Ravi Mehrotra
Journal:  Lancet Oncol       Date:  2018-02       Impact factor: 41.316

Review 5.  Advancing psychosocial care in cancer patients.

Authors:  Luigi Grassi; David Spiegel; Michelle Riba
Journal:  F1000Res       Date:  2017-12-04

6.  High-Risk Adult Wilms' Tumour in Pregnancy: A Case Report.

Authors:  Stephen Kasenda; Donnie Mategula; Noel Chiphangwi; Luis Aaron Gadama; Leo Peter Lockie Masamba
Journal:  Malawi Med J       Date:  2019-06       Impact factor: 0.875

7.  Scoping the psychological support practices of Australian health professionals working with people with primary brain tumor and their families.

Authors:  Tamara Ownsworth; Katarzyna Lion; Ursula M Sansom-Daly; Kerryn Pike; Eng-Siew Koh; Georgia K B Halkett; Mark B Pinkham; Raymond J Chan; Haryana M Dhillon
Journal:  Psychooncology       Date:  2022-04-02       Impact factor: 3.955

8.  Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society.

Authors:  Christoph Kowalski; Ullrich Graeven; Christof von Kalle; Hauke Lang; Matthias W Beckmann; Jens-Uwe Blohmer; Martin Burchardt; Michael Ehrenfeld; Jan Fichtner; Stephan Grabbe; Hans Hoffmann; Heinrich Iro; Stefan Post; Anton Scharl; Uwe Schlegel; Thomas Seufferlein; Walter Stummer; Dieter Ukena; Julia Ferencz; Simone Wesselmann
Journal:  BMC Cancer       Date:  2017-12-14       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.